Back
Alaunos Therapeutics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
29
TCRT
Alaunos Therapeutics
Last Price:
1.31
Seasonality Move:
10.72%
Sell
40
NRBO
NeuroBo Pharmaceuticals
Last Price:
3.82
Seasonality Move:
-6.61%
Sell
29
Alaunos Therapeutics (TCRT)
is a Sell
Is Alaunos Therapeutics a Buy, Sell or Hold?
- The current Alaunos Therapeutics [TCRT] share price is $1.32. The Score for TCRT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- TCRT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $3.87. The Score for NRBO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCRT Stock Price Chart
What is Alaunos Therapeutics's stock price today?
-
The Alaunos Therapeutics share price today is $1.32
The current trend is relatively stagnant and TCRT is experiencing slight buying pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $3.87
The current trend is relatively stagnant and NRBO is experiencing slight buying pressure.
TCRT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 43.63 | Sell |
| Chaikin Money Flow: | 8628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.65) | Sell |
| Bollinger Bands (100): | (1.19 - 2.21) | Sell |
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 56.58 | Buy |
| Chaikin Money Flow: | 6153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.22 - 3.82) | Buy |
| Bollinger Bands (100): | (3.27 - 4.97) | Sell |
TCRT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.34 | Sell |
| 50-day SMA: | 1.66 | Sell |
| 200-day SMA: | 2.06 | Sell |
| 8-day EMA: | 1.3 | Buy |
| 20-day EMA: | 1.37 | Sell |
| 50-day EMA: | 1.55 | Sell |
| 200-day EMA: | 3.01 | Sell |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.47 | Buy |
| 20-day SMA: | 3.42 | Buy |
| 50-day SMA: | 4.23 | Sell |
| 200-day SMA: | 3.99 | Sell |
| 8-day EMA: | 3.58 | Buy |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.89 | Sell |
| 200-day EMA: | 8.73 | Sell |
Alaunos Therapeutics Earnings Growth & TCRT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.65 per share, and a decrease next year of $1.35 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alaunos Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroBo Pharmaceuticals Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||